Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 9245702, 13 pages
https://doi.org/10.1155/2017/9245702
Research Article

Vitamin D Receptor Activation Influences NADPH Oxidase (NOX2) Activity and Protects against Neurological Deficits and Apoptosis in a Rat Model of Traumatic Brain Injury

1Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, China
2School of Basic Medical Science, North China University of Science and Technology, Tangshan, Hebei 063000, China
3Department of Neurosurgery, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China
4Department of Neurosurgery, Affiliated Hospital of Taishan Medical University, Taian, Shandong 271000, China
5Department of Neurosurgery, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China
6Institute of Clinical Pharmacy and Pharmacology, Jining First People’s Hospital, Jining Medical University, Jining, Shandong 272000, China

Correspondence should be addressed to Junling Gao and Pei Jiang

Received 5 April 2017; Revised 18 July 2017; Accepted 30 July 2017; Published 19 December 2017

Academic Editor: Arsenio Fernández-López

Copyright © 2017 Changmeng Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. S. Budinich, L. B. Tucker, D. Lowe, J. G. Rosenberger, and J. T. McCabe, “Short and long-term motor and behavioral effects of diazoxide and dimethyl sulfoxide administration in the mouse after traumatic brain injury,” Pharmacology Biochemistry and Behavior, vol. 108, no. 3, pp. 66–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Faul, L. Xu, M. M. Wald, V. Coronado, and A. M. Dellinger, “Traumatic brain injury in the United States: national estimates of prevalence and incidence, 2002–2006,” Injury Prevention, vol. 16, article A268, Supplement 1, 2010. View at Publisher · View at Google Scholar
  3. J. W. Finnie, “Pathology of traumatic brain injury,” Veterinary Research Communications, vol. 38, no. 4, pp. 297–305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. I. Maas, N. Stocchetti, and R. Bullock, “Moderate and severe traumatic brain injury in adults,” The Lancet Neurology, vol. 7, no. 8, pp. 728–741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Vink and D. H. C. Van, “Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury,” Expert Opinion on Investigational Drugs, vol. 13, no. 10, pp. 1263–1274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. B. M. Babior, “NADPH oxidase,” Current Opinion in Immunology, vol. 16, no. 1, pp. 42–47, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Ano, A. Sakudo, T. Kimata, R. Uraki, K. Sugiura, and T. Onodera, “Oxidative damage to neurons caused by the induction of microglial NADPH oxidase in encephalomyocarditis virus infection,” Neuroscience Letters, vol. 469, no. 1, pp. 39–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. X. Song, J. L. Gao, K. J. Wang et al., “Attenuation of brain edema and spatial learning deficits by the inhibition of NADPH oxidase activity using apocynin following diffuse traumatic brain injury in rats,” Molecular Medicine Reports, vol. 7, no. 1, pp. 327–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Y. Choi, B. G. Jang, J. H. Kim et al., “Prevention of traumatic brain injury-induced neuronal death by inhibition of NADPH oxidase activation,” Brain Research, vol. 1481, no. 30, pp. 49–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Jiang, Y. Xue, H. D. Li et al., “Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone,” Psychopharmacology, vol. 231, no. 17, pp. 3445–3451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. D. W. Eyles, T. H. J. Burne, and J. J. Mcgrath, “Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease,” Frontiers in Neuroendocrinology, vol. 34, no. 1, pp. 47–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. G. Pittas, S. S. Harris, P. C. Stark, and B. Dawson-Hughes, “The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults,” Diabetes Care, vol. 30, no. 4, pp. 980–986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Jorde, E. B. Mathiesen, S. Rogne et al., “Vitamin D and cognitive function: the Tromsø Study,” Journal of the Neurological Sciences, vol. 355, no. 1-2, pp. 155–161, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Segaert, H. Degreef, and R. Bouillon, “Vitamin D receptor expression is linked to cell cycle control in normal human keratinocytes,” Biochemical and Biophysical Research Communications, vol. 279, no. 1, pp. 89–94, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. T. F. Mcguire and J. C. T. Dl, “Vitamin D3-induced apoptosis of murine squamous cell carcinoma cells - selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1,” Journal of Biological Chemistry, vol. 276, no. 28, pp. 26365–26373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Dang, P. Jiang, H. Cai et al., “Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: involvement of the INSIG/SREBP pathway,” European Neuropsychopharmacology, vol. 25, no. 8, pp. 1239–1247, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. L. Evatt, M. R. Delong, N. Khazai, A. Rosen, S. Triche, and V. Tangpricha, “Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease,” Archives of Neurology, vol. 65, no. 10, pp. 1348–1352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Wirrell, “Vitamin D and bone health in children with epilepsy: fad or fact?” Pediatric Neurology, vol. 42, no. 6, pp. 394-395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Hua, J. I. Reiss, H. Tang et al., “Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury,” Hormones and Behavior, vol. 61, no. 4, pp. 642–651, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Jiang, L. H. Zhang, H. L. Cai et al., “Neurochemical effects of chronic administration of calcitriol in rats,” Nutrients, vol. 6, no. 12, pp. 6048–6059, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Feng, Y. Cui, J. L. Gao et al., “Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-κB signaling pathway in experimental traumatic brain injury,” International Journal of Molecular Medicine, vol. 37, no. 4, pp. 921–930, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Baroni, B. Camisa, and D. D'Ambrosio, “Inter-species differences in sensitivity to the calcemic activity of the novel 1,25-dihydroxyvitamin D3 analog BXL746,” Regulatory Toxicology and Pharmacology, vol. 52, no. 3, pp. 332–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Fu, R. Xue, J. Gu et al., “Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus,” Molecular Medicine Reports, vol. 8, no. 6, pp. 1708–1714, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Feng, J. Gao, Y. Cui et al., “Neuroprotective effects of resatorvid against traumatic brain injury in rat: involvement of neuronal autophagy and TLR4 signaling pathway,” Cellular and Molecular Neurobiology, vol. 37, no. 1, pp. 155–168, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Thakkar, R. Wang, G. Sareddy et al., “NLRP3 Inflammasome activation in the brain after global cerebral ischemia and regulation by 17β-estradiol,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8309031, 17 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Kozlowski and R. M. Weimer, “An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo,” PLoS One, vol. 7, article e31814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Wang, Q. Wu, W. Wu et al., “Mitochondrial ferritin deletion exacerbates β-amyloid-induced neurotoxicity in mice,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1020357, 10 pages, 2017. View at Publisher · View at Google Scholar
  28. J. Jia, L. Ma, M. Wu et al., “Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 893516, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Cui, Y. Cui, J. Gao et al., “Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury,” Neurological Sciences, vol. 35, no. 5, pp. 695–700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Liu, L. Li, and W. Z. Suo, “HT22 hippocampal neuronal cell line possesses functional cholinergic properties,” Life Sciences, vol. 84, no. 9-10, pp. 267–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. W. Unterberg, J. Stover, B. Kress, and K. L. Kiening, “Edema and brain trauma,” Neuroscience, vol. 129, no. 4, pp. 1019–1027, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Schilling and M. Wahl, “Mediators of cerebral edema,” Oxygen Transport to Tissue XXXIII, vol. 474, pp. 123–141, 1999. View at Google Scholar
  33. P. Hellman, W. Liu, G. Westin, H. Törmä, and G. Akerström, “Vitamin D and retinoids in parathyroid glands (review),” International Journal of Molecular Medicine, vol. 3, no. 4, pp. 355–361, 1999. View at Publisher · View at Google Scholar
  34. J. H. Hwang, T. Wang, K. S. Lee, J. K. Joo, and H. G. Lee, “Vitamin D binding protein plays an important role in the progression of endometriosis,” International Journal of Molecular Medicine, vol. 32, no. 6, pp. 1394–1400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Bouillon, G. Carmeliet, L. Verlinden et al., “Vitamin D and human health: lessons from vitamin D receptor null mice,” Endocrine Reviews, vol. 29, no. 6, pp. 726–776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. D. Brewer, V. Thibault, K. C. Chen, M. C. Langub, P. W. Landfield, and N. M. Porter, “Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons,” Journal of Neuroscience, vol. 21, no. 1, pp. 98–108, 2001. View at Google Scholar
  37. G. D. Kutuzova and H. F. Deluca, “Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties,” Archives of Biochemistry and Biophysics, vol. 432, no. 2, pp. 152–166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Cekic, I. Sayeed, and D. G. Stein, “Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 158–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. V. Kalueff, K. O. Eremin, and P. Tuohimaa, “Mechanisms of neuroprotective action of vitamin D3,” Biochemistry, vol. 69, no. 7, pp. 738–741, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Imazeki, J. Matsuzaki, K. Tsuji, and T. Nishimura, “Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity,” Biomedical Research, vol. 27, no. 1, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. B. D. Mahon, A. Wittke, V. Weaver, and M. T. Cantorna, “The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells,” Journal of Cellular Biochemistry, vol. 89, no. 5, pp. 922–932, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Shinpo, S. Kikuchi, H. Sasaki, F. Moriwaka, and K. Tashiro, “Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine,” Journal of Neuroscience Research, vol. 62, no. 3, pp. 374–382, 2000. View at Publisher · View at Google Scholar
  43. J. F. Chabas, O. Alluin, G. Rao et al., “Vitamin D2 potentiates axon regeneration,” Journal of Neurotrauma, vol. 25, no. 10, pp. 1247–1256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. K. A. Jackman, A. A. Miller, T. M. de Silva, P. J. Crack, G. R. Drummond, and C. G. Sobey, “Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice,” British Journal of Pharmacology, vol. 156, no. 4, pp. 680–688, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Dohi, H. Ohtaki, T. Nakamachi et al., “Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury,” Journal of Neuroinflammation, vol. 7, no. 1, p. 41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. Ansari, K. N. Roberts, and S. W. Scheff, “Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury,” Free Radical Biology & Medicine, vol. 45, no. 4, pp. 443–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Dong, S. L. Wong, C. W. Lau et al., “Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress,” European Heart Journal, vol. 33, no. 23, pp. 2980–2990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Raghupathi, D. I. Graham, and T. K. McIntosh, “Apoptosis after traumatic brain injury,” Journal of Neurotrauma, vol. 17, no. 10, pp. 927–938, 2000. View at Publisher · View at Google Scholar
  49. M. Tamatani, S. Ogawa, Y. Niitsu, and M. Tohyama, “Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis,” Journal of Neurochemistry, vol. 71, no. 4, pp. 1588–1596, 1998. View at Publisher · View at Google Scholar
  50. Y. Oshima, T. Akiyama, A. Hikita et al., “Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis,” Journal of Biological Chemistry, vol. 283, no. 39, pp. 26499–26508, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Tortosa, E. López, and I. Ferrer, “Bcl-2 and Bax proteins in lewy bodies from patients with Parkinson’s disease and diffuse Lewy body disease,” Neuroscience Letters, vol. 238, no. 1-2, pp. 78–80, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Yang, X. Liu, K. Bhalla et al., “Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked,” Science, vol. 275, no. 5303, pp. 1129–1132, 1997. View at Publisher · View at Google Scholar · View at Scopus